CINCINNATI, Oct. 10 /PRNewswire-FirstCall/ -- Kendle will conduct a telephone conference call and simultaneous Webcast on Oct. 31 at 8:30 a.m. Eastern Time to discuss its financial results for Third Quarter 2006. A question and answer session will follow.
(Logo: http://www.newscom.com/cgi-bin/prnh/20030429/KNDLLOGO)
Webcast Instructions
To access the live Webcast, go to http://www.kendle.com or http://www.videonewswire.com/event.asp?id=36086. Instructions for accessing the Webcast are provided at both sites. The Webcast will be archived at http://www.kendle.com (click on “Investors”) shortly after the call for on- demand replay through 5 p.m. Eastern Time on Nov. 30. Please note that Webcast participants will not be able to ask questions.
System requirements for the Webcast include Windows Media Player software and at least a 28.8 Kbps connection to the Internet. Media Player is downloadable at no charge from http://www.microsoft.com/windows/windowsmedia/default.aspx.
Conference Call Instructions
To register (RSVP) for the telephone conference call, U.S. and Canadian participants should dial (800) 223-7104. Participants outside North America should dial (706) 645-6519.
To participate in the telephone conference call, interested parties in the United States and Canada should dial (800) 399-0069. Participants outside North America should dial (706) 643-3694. A replay will be available through 5 p.m. Eastern Time on Nov. 30 by dialing (706) 645-9291 and entering conference ID number 4134311.
About Kendle
Kendle International Inc. is among the world’s leading global clinical research organizations and is the fourth-largest provider of Phase II-IV clinical development services worldwide. We deliver innovative and robust clinical development solutions - from first-in-human studies through market launch and surveillance - to help the world’s biopharmaceutical companies maximize product life cycles and grow market share. Our global clinical development business is focused on five regions - North America, Europe, Asia/Pacific, Latin America and Africa - to meet customer needs. With the expertise of our associates worldwide, Kendle has conducted clinical trials or provided regulatory, pharmacovigilance and validation services in 70 countries. Additional information and investor kits are available upon request from Kendle, 1200 Carew Tower, 441 Vine Street, Cincinnati, OH 45202 or from the Company’s Web site at http://www.kendle.com.
Photo: http://www.newscom.com/cgi-bin/prnh/20030429/KNDLLOGOAP Archive: http://photoarchive.ap.orgPRN Photo Desk, photodesk@prnewswire.comKendle International Inc.
CONTACT: Buzz Brenkert, Investors, +1-513-345-1525, or Lori Dorer, Media,+1-513-345-1685, both of Kendle International Inc.
